These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 21526941

  • 1. Tularemia vaccines: recent developments and remaining hurdles.
    Conlan JW.
    Future Microbiol; 2011 Apr; 6(4):391-405. PubMed ID: 21526941
    [Abstract] [Full Text] [Related]

  • 2. Live Attenuated Tularemia Vaccines for Protection Against Respiratory Challenge With Virulent F. tularensis subsp. tularensis.
    Jia Q, Horwitz MA.
    Front Cell Infect Microbiol; 2018 Apr; 8():154. PubMed ID: 29868510
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A ΔclpB mutant of Francisella tularensis subspecies holarctica strain, FSC200, is a more effective live vaccine than F. tularensis LVS in a mouse respiratory challenge model of tularemia.
    Golovliov I, Twine SM, Shen H, Sjostedt A, Conlan W.
    PLoS One; 2013 Apr; 8(11):e78671. PubMed ID: 24236032
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis.
    KuoLee R, Harris G, Conlan JW, Chen W.
    Vaccine; 2007 May 10; 25(19):3781-91. PubMed ID: 17346863
    [Abstract] [Full Text] [Related]

  • 7. BALB/c mice, but not C57BL/6 mice immunized with a ΔclpB mutant of Francisella tularensis subspecies tularensis are protected against respiratory challenge with wild-type bacteria: association of protection with post-vaccination and post-challenge immune responses.
    Twine S, Shen H, Harris G, Chen W, Sjostedt A, Ryden P, Conlan W.
    Vaccine; 2012 May 21; 30(24):3634-45. PubMed ID: 22484348
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Vaccines against Francisella tularensis.
    Wayne Conlan J, Oyston PC.
    Ann N Y Acad Sci; 2007 Jun 21; 1105():325-50. PubMed ID: 17395730
    [Abstract] [Full Text] [Related]

  • 11. Deletion of IglH in virulent Francisella tularensis subsp. holarctica FSC200 strain results in attenuation and provides protection against the challenge with the parental strain.
    Straskova A, Cerveny L, Spidlova P, Dankova V, Belcic D, Santic M, Stulik J.
    Microbes Infect; 2012 Feb 21; 14(2):177-87. PubMed ID: 21930232
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Vaccines against Francisella tularensis--past, present and future.
    Conlan JW.
    Expert Rev Vaccines; 2004 Jun 21; 3(3):307-14. PubMed ID: 15176947
    [Abstract] [Full Text] [Related]

  • 14. Construction and characterization of an attenuated purine auxotroph in a Francisella tularensis live vaccine strain.
    Pechous R, Celli J, Penoske R, Hayes SF, Frank DW, Zahrt TC.
    Infect Immun; 2006 Aug 21; 74(8):4452-61. PubMed ID: 16861631
    [Abstract] [Full Text] [Related]

  • 15. A defined O-antigen polysaccharide mutant of Francisella tularensis live vaccine strain has attenuated virulence while retaining its protective capacity.
    Sebastian S, Dillon ST, Lynch JG, Blalock LT, Balon E, Lee KT, Comstock LE, Conlan JW, Rubin EJ, Tzianabos AO, Kasper DL.
    Infect Immun; 2007 May 21; 75(5):2591-602. PubMed ID: 17296751
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Intranasal vaccination induces protective immunity against intranasal infection with virulent Francisella tularensis biovar A.
    Wu TH, Hutt JA, Garrison KA, Berliba LS, Zhou Y, Lyons CR.
    Infect Immun; 2005 May 21; 73(5):2644-54. PubMed ID: 15845466
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.